Key result
Cognitive-behavioral stress management improves psychosocial well-being in male CAD patients but fails to reduce cortisol levels.
Why the study?
Behavioral therapy affects stress behavior in patients with coronary artery disease and salivary cortisol is widely used to assess psychological stress, but whether improved stress behavior in type A patients involves changes in cortisol secretion pattern was unknown.
Does a 12-month cognitive-behavioral stress management program change salivary cortisol secretion patterns in male patients with coronary artery disease and type A behavior?
Observational (n=24)
No
Does a 12-month cognitive-behavioral stress management program change salivary cortisol secretion patterns in male patients with coronary artery disease and type A behavior?
Although cognitive-behavioral stress management improves self-reported psychosocial stress in male CAD patients with type A behavior, salivary cortisol levels remain unchanged, questioning the utility of salivary cortisol as a stress biomarker in cardiac rehabilitation.
Psychosocial benefits from stress management in type A CAD patients occur without cortisol shifts; leaves open salivary cortisol's validity as a rehabilitation biomarker.
In Brief PURPOSE It has been shown that behavioral therapy has effects on stress behavior in patients with coronary artery disease. Salivary cortisol measurements are widely used to assess psychological stress, stress reactivity, or both. The aim of this study was to investigate whether improved stress behavior in type A patients with coronary artery disease involved changes in cortisol secretion pattern. METHODS Twenty-four male patients were identified as type A individuals and completed a 12-month cognitive-behavioral stress management program. Stress behavior was evaluated by using a validated questionnaire. Morning and evening salivary cortisol levels were measured over 3 consecutive days at baseline and after 12 months. RESULTS Although the patients showed a significant improvement in psychosocial well-being after 12 months, their basal cortisol levels or diurnal rhythm of cortisol did not change. There was no correlation between stress score and cortisol levels. CONCLUSIONS The value of salivary cortisol as both a stress marker and a new cardiovascular risk factor has been discussed but the data from this small pilot study raise the question of its utility as a stress marker in cardiac rehabilitation. Salivary cortisol has become a widely used stress marker. Patients with coronary artery disease, identified as type A individuals, completed a 12-month cognitive- behavioral stress management program. Although they showed a significant improvement in psychosocial well-being after 12 months, their basal cortisol levels or diurnal rhythm of cortisol did not change.
No takes yet. Share an insight, caveat, or question.
Rydén et al. (2009) conducted an observational in Coronary artery disease with type A behavior (n=24). Cognitive-behavioral stress management program vs. Baseline pre-intervention measurements (single-arm study) was evaluated on Salivary cortisol levels (30 minutes after awakening, evening, and diurnal deviation) at 12 months (p=NS). A 12-month cognitive-behavioral stress management program improved psychosocial well-being in male CAD patients with type A behavior but did not significantly change morning (10.9 vs 11.7 nmol/l, p=NS) or evening (1.6 vs 1.4 nmol/l, p=NS) salivary cortisol levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: